HCW Biologics Inc.
HCWB
$1.18
-$0.27-18.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 719.20K | -4.55M | -1.93M | -2.20M | -3.37M |
| Total Depreciation and Amortization | 156.90K | 173.90K | 291.90K | 419.00K | 682.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.87M | 1.35M | -1.60M | 425.60K | 292.10K |
| Change in Net Operating Assets | -361.70K | -213.40K | -45.00K | -2.16M | -436.20K |
| Cash from Operations | -3.36M | -3.24M | -3.28M | -3.51M | -2.83M |
| Capital Expenditure | -- | -- | -- | -- | -113.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -113.40K |
| Total Debt Issued | 0.00 | 0.00 | 150.00K | -- | 375.00K |
| Total Debt Repaid | -32.80K | -31.40K | -30.90K | -32.50K | -31.00K |
| Issuance of Common Stock | 742.40K | 1.99M | 5.30M | 1.70K | 3.96M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.50M | -63.50K | -802.60K | -22.30K | 2.32M |
| Cash from Financing | 4.21M | 1.90M | 4.61M | -53.10K | 6.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 855.60K | -1.34M | 1.33M | -3.57M | 3.68M |